Table 1.
N = 120 (range), (%) | ||
---|---|---|
Median age at enrollment (y) | 59 (24-89) | |
Female | 58 (48.0) | |
Race | ||
Non-Hispanic White | 77 (64.0) | |
Hispanic | 14 (11.7) | |
Asian | 11 (9.2) | |
Black | 8 (6.7) | |
Cancer type | ||
Myeloma | 50 (41.7) | |
Non-indolent lymphoma | 21 (17.5) | |
Acute myeloid leukemia | 18 (15.0) | |
Myeloproliferative neoplasm | 14 (11.7) | |
Reasons for referral | ||
Pain | 72 (60.0) | |
Mood | 15 (12.5) | |
Fatigue | 9 (7.5) | |
Goals of care conversations before HSCT | 12 (10.0) |
Reasons for hospitalization | Before PC | After PC |
---|---|---|
Chemotherapy/radiotherapy | 21 | 10 |
Pain | 7 | 4 |
New cancer diagnosis | 3 | 0 |
Relapsed disease | 3 | 0 |
Orthopedic procedure | 2 | 1 |
Hernia | 2 | 0 |
Biopsy | 2 | 0 |
Viral upper respiratory infection | 2 | 2 |
Treatment toxicity | 1 | 0 |
Gastric anastomotic leak | 1 | 0 |
Pacemaker placement | 1 | 0 |
Myocardial infarction | 1 | 0 |
Dysphagia | 1 | 0 |
Fever | 1 | 5 |
Bowel ischemia | 1 | 0 |
Nausea/vomiting | 1 | 1 |
Gastrointestinal bleeding | 1 | 1 |
Failure to thrive | 1 | 0 |
Altered mental status | 1 | 0 |
Bacterial infection | 0 | 3 |
Disease progression | 0 | 2 |
Subdural hematoma | 0 | 1 |
Adrenal insufficiency | 0 | 1 |
Acute kidney injury | 0 | 1 |